According to PURE Bioscience latest financial reports the cash on hand of PURE is $1.09M, an decrease of -67.71% to 2022. At the end of 2022 company had $3.39M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $1.09M | -67.71% |
2022 | $3.39M | 41.88% |
2021 | $2.39M | -37.74% |
2020 | $3.84M | 864.57% |
2019 | $398.00K | - |